Qiming U.S. Ventures Management, LLC
CIK 1909617 · View on SEC EDGAR ↗
- Portfolio value
- $55.6M
- Positions
- 4
- As of
- Sept. 30, 2025 Data as of Q3 2025
Portfolio value QoQ: +135.6% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 3
- Effective number of positions
- 2.0
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q3 2025: 0.0% Est. buys $0 · sells $1,623,666
Median holding: 4.0 quarters Tracked Q4 2024–Q3 2025 · 66.7% still held
- New positions
- 0
- Increased
- 0
- Decreased
- 0
- Closed
- 2
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: +20.4% · S&P 500: +18.3%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 99.2% · Options excluded: 0.0%
Sector breakdown
Full portfolio 4 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| TRML Tourmaline Bio, Inc. - Common Stock | $35,475,081 | 63.76% | 741,691 | $23,615,442 | |||
| KRRO Korro Bio, Inc. - Common Stock | $17,627,591 | 31.68% | 368,085 | $13,030,209 | |||
| JSPR Jasper Therapeutics, Inc. - Class A Common Stock | $2,210,934 | 3.97% | 928,964 | $-2,944,816 | |||
| KZR Kezar Life Sciences, Inc. - Common Stock | $323,197 | 0.58% | 82,871 | $-56,352 | |||
| No matches | |||||||
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| VTYX | Sept. 30, 2025 | 412,225 | $882,162 | No longer tracked |
| HLVX | Sept. 30, 2025 | 372,615 | $741,504 | No longer tracked |